• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔内及皮下注射吗啡对原发性肺癌或肺转移终末期患者静息时呼吸困难的影响。

Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.

作者信息

Gamborg Helle, Riis Jette, Christrup Lona, Krantz Torben

机构信息

Sankt Lukas Hospice, Bernstorffsvej 20, DK-2900 Hellerup, Denmark.

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, DK-2100 Copenhagen Ø.

出版信息

J Opioid Manag. 2013 Jul-Aug;9(4):269-74. doi: 10.5055/jom.2013.0168.

DOI:10.5055/jom.2013.0168
PMID:24353020
Abstract

BACKGROUND

Dyspnea is considered as one of the most frequent and distressing symptoms in patients with advanced cancer, and systemic administration of morphine has been reported to have beneficial effect on this complaint.

AIM AND DESIGN

The effect of red morphine drops (RMD) given orally and kept in the mouth as long as possible before swallowing to alleviate dyspnea was compared to the effect of morphine given subcutaneously (SCM) in a double-blind, double-dummy trial.

PARTICIPANTS

Twenty consecutive terminally ill patients with primary lung cancer or lung metastases admitted to Sankt Lukas Hospice were included in the study. All patients had dyspnea at rest, and they received either 1/12 of their 24-hour morphine dose as RMD or 60 percent of this dose as SCM. Perceived breathlessness was evaluated on a Visual Analogue Scale (VAS) during a 60 minutes observation time, and pulse rate, respiratory rate and oxygen saturation were assessed as well.

RESULTS

Compared to baseline both RMD and SCM showed a small, but statistical significant effect on VAS (mean decrease of 1.1 [RMD] and 1.7 [SCM]) and pulse rate (mean decrease of 4 per minute [RMD] and 6 per minute [SCM]), the effect being significantly larger after SCM.

CONCLUSIONS

The study confirms the beneficial effect of morphine on dyspnea in terminally ill patients, and we conclude that RMD is an attractive alternative to injected morphine, when self-administration is preferable.

摘要

背景

呼吸困难被认为是晚期癌症患者最常见且痛苦的症状之一,据报道吗啡全身给药对该症状有有益作用。

目的与设计

在一项双盲、双模拟试验中,比较了口服红色吗啡滴剂(RMD)并在吞咽前尽可能长时间含于口中以缓解呼吸困难的效果与皮下注射吗啡(SCM)的效果。

参与者

连续纳入了20名入住圣卢卡斯临终关怀院的晚期原发性肺癌或肺转移患者。所有患者静息时均有呼吸困难,他们接受24小时吗啡剂量的1/12作为RMD或该剂量的60%作为SCM。在60分钟观察期内通过视觉模拟量表(VAS)评估主观呼吸困难程度,并评估脉搏率、呼吸频率和血氧饱和度。

结果

与基线相比,RMD和SCM对VAS(平均下降1.1[RMD]和1.7[SCM])和脉搏率(平均每分钟下降4次[RMD]和6次[SCM])均显示出较小但具有统计学意义的效果,SCM后的效果明显更大。

结论

该研究证实了吗啡对晚期患者呼吸困难的有益作用,我们得出结论,当更倾向于自我给药时,RMD是注射用吗啡的一种有吸引力的替代方法。

相似文献

1
Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.口腔内及皮下注射吗啡对原发性肺癌或肺转移终末期患者静息时呼吸困难的影响。
J Opioid Manag. 2013 Jul-Aug;9(4):269-74. doi: 10.5055/jom.2013.0168.
2
[Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].[控释羟考酮治疗癌症患者呼吸困难的疗效——三个病例系列]
Gan To Kagaku Ryoho. 2006 Apr;33(4):529-32.
3
Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.雾化吸入与皮下注射吗啡治疗癌症患者呼吸困难的初步研究。
J Pain Symptom Manage. 2005 Jun;29(6):613-8. doi: 10.1016/j.jpainsymman.2004.08.016.
4
Oral morphine drops for prompt relief of breathlessness in patients with advanced cancer-a randomized, double blinded, crossover trial of morphine sulfate oral drops vs. morphine hydrochloride drops with ethanol (red morphine drops).口服吗啡滴剂迅速缓解晚期癌症患者呼吸困难的随机、双盲、交叉试验:硫酸吗啡滴剂与盐酸吗啡加乙醇滴剂(红吗啡滴剂)的比较。
Support Care Cancer. 2020 Jul;28(7):3421-3428. doi: 10.1007/s00520-019-05116-1. Epub 2019 Dec 2.
5
Fentanyl Sublingual Tablets Versus Subcutaneous Morphine for the Management of Severe Cancer Pain Episodes in Patients Receiving Opioid Treatment: A Double-Blind, Randomized, Noninferiority Trial.芬太尼舌下片与皮下注射吗啡治疗接受阿片类药物治疗的中重度癌痛患者爆发性疼痛的双盲、随机、非劣效性试验。
J Clin Oncol. 2017 Mar;35(7):759-765. doi: 10.1200/JCO.2016.69.9504. Epub 2017 Jan 23.
6
Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients.持续静脉输注吗啡治疗晚期间质性肺炎患者的严重呼吸困难
Intern Med. 2016;55(7):725-9. doi: 10.2169/internalmedicine.55.5362. Epub 2016 Apr 1.
7
Nebulized morphine in the palliation of dyspnoea.
Palliat Med. 1997 Jul;11(4):267-75. doi: 10.1177/026921639701100402.
8
Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series.口服黏膜用枸橼酸芬太尼用于晚期患者呼吸困难:一项观察性病例系列研究
J Palliat Med. 2008 May;11(4):643-8. doi: 10.1089/jpm.2007.0161.
9
The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial.吗啡对晚期癌症老年患者呼吸困难及通气功能的影响:一项随机双盲对照试验。
Ann Oncol. 1999 Dec;10(12):1511-4. doi: 10.1023/a:1008337624200.
10
Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer.
Palliat Med. 1997 Jul;11(4):277-81. doi: 10.1177/026921639701100403.

引用本文的文献

1
Palliative patients who may benefit from intranasal delivery of symptomatic drugs: a two-center observational study evaluated the administration of morphine and dexamethasone in Polish hospices.可能从鼻内给药的对症药物中获益的姑息治疗患者:一项双中心观察性研究评估了波兰临终关怀机构中吗啡和地塞米松的给药情况。
Support Care Cancer. 2025 Feb 1;33(2):140. doi: 10.1007/s00520-025-09189-z.
2
Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.药物干预对晚期癌症患者呼吸困难的影响:系统评价和荟萃分析。
JAMA Netw Open. 2021 Feb 1;4(2):e2037632. doi: 10.1001/jamanetworkopen.2020.37632.
3
Use of short-acting opioids in the management of breathlessness: an evidence-based review.
短效阿片类药物在呼吸困难管理中的应用:基于证据的综述。
Curr Opin Support Palliat Care. 2020 Sep;14(3):167-176. doi: 10.1097/SPC.0000000000000509.
4
Patients with End-stage Interstitial Lung Disease may have More Problems with Dyspnea than End-stage Lung Cancer Patients.终末期间质性肺疾病患者可能比终末期肺癌患者有更多的呼吸困难问题。
Indian J Palliat Care. 2016 Jul-Sep;22(3):282-7. doi: 10.4103/0973-1075.185035.